Emtriva and pulmonary embolism Patient Reports February 11, 2012
Emtriva Side Effects Report #4712312-2
Emtriva side effect was reported by a Health Professional from FRANCE on June 24, 2005. Female patient, 57 years of age, was diagnosed with hiv infection
, pneumocystis jiroveci pneumonia and was treated with Emtriva. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Emtriva dosage: 200 MG, 1 IN 1 D, ORAL. During the same period patient was treated with KALETRA, ATOVAQUONE. Patient recovered.Emtriva Side Effects Report #4730031-3
Emtriva side effect was reported by a Health Professional from FRANCE on June 24, 2005. Female patient, 57 years of age, was diagnosed with acquired immunodeficiency syndrome, pneumocystis jiroveci pneumonia and was treated with Emtriva. After drug was administered, patient experienced the following side effects: nodule, pulmonary embolism
. Emtriva dosage: unknown. During the same period patient was treated with KALETRA, WELLVONE, IMOVANE, ZYPREXA, DEPAKOTE. Patient recovered.Emtriva Side Effects Report #4737930-7
Emtriva side effect was reported by a Health Professional from FRANCE on July 18, 2005. Female patient, 57 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with Emtriva. After drug was administered, patient experienced the following side effects: electrocardiogram abnormal, hypocapnia, hypoxia, international normalised ratio abnormal, nodule, pulmonary embolism
, restrictive pulmonary disease. Emtriva dosage: 200 MG, 1 IN 1 D, ORAL. During the same period patient was treated with KALETRA, WELLVONE, IMOVANE, ZYPREXA, DEPAKOTE. Patient recovered.Emtriva Side Effects Report #4774779-3
Emtriva side effect was reported by a Health Professional from FRANCE on June 24, 2005. Female patient, 57 years of age, was diagnosed with acquired immunodeficiency syndrome, pneumocystis jiroveci pneumonia and was treated with Emtriva. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Emtriva dosage: unknown. During the same period patient was treated with KALETRA, WELLVONE, IMOVANE, ZYPREXA, DEPAKOTE. Patient recovered.Emtriva Side Effects Report #4785145-9
Emtriva side effect was reported by a Health Professional from FRANCE on Sept 13, 2005. Female patient, 57 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with Emtriva. After drug was administered, patient experienced the following side effects: pulmonary embolism
, restrictive pulmonary disease. Emtriva dosage: 200 MG, 1 IN 1 D, ORAL. During the same period patient was treated with KALETRA, WELLVONE, IMOVANE, XYPREXA, DEPAKOTE. Patient recovered.
Emtriva and pulmonary embolism 